Jeremy R A Paull
5PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Aug 01, 2025
Dendrimer-Nanoparticle (DEP) Delivery of Topoisomerase I Inhibitor, SN38 (DEP-SN38): Safety, Tolerability, and Preliminary Efficacy Study in Patients With Advanced Solid Tumors.Jia Liu, Anna R Minchom, Alastair Greystoke
|Sep 28, 2024
Astodrimer Sodium Nasal Spray versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blinded, Placebo-Controlled Trial.Stephen Winchester, Alex Castellarnau, Kashif Jabbar
|Aug 28, 2021
Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice.Jeremy R A Paull, Carolyn A Luscombe, Alex Castellarnau
|Jul 02, 2021
Topical Astodrimer Sodium, a Non-Toxic Polyanionic Dendrimer, Demonstrates Antiviral Activity in an Experimental Ocular Adenovirus Infection Model.Eric G Romanowski, Kathleen A Yates, Jeremy R A Paull
|May 05, 2020
A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis.Arthur S Waldbaum, Jane R Schwebke, Jeremy R A Paull
Pageof 1
Frequent Collaborators
1 joint publications
Eric G Romanowski
1 joint publications
Graham P Heery
1 joint publications
Isaac John
1 joint publications
Jia Liu
1 joint publications
Anna R Minchom
1 joint publications
Alastair Greystoke
1 joint publications
Debashis Sarker
1 joint publications
Anthony M Joshua
1 joint publications
Cienne Morton
1 joint publications
Jordan E Cohen
